SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2141864

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2141864

Advanced Therapy Medicinal Products Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 293 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Advanced Therapy Medicinal Products Market Projected to Reach US$48.04 Bn by 2033

Introduction

The global advanced therapy medicinal products market is valued at US$18.5 Bn in 2026 and projected to reach US$48.04 Bn by 2033, at a CAGR of 14.6% during 2026-2033. Fairfield Market Research assesses the market through its published product, customer and geographical classifications. The forecast provides a common basis for evaluating commercial priorities across the study period.

Market Insights

The product type breakdown covers Cell Therapies, Gene Therapies, Tissue-Engineered Products and Others. The application breakdown covers Oncology, Rare Genetic Disorders and Others. The end user breakdown covers Hospitals & Specialty Treatment Centers and Research Institutes. These distinctions help businesses assess which offerings and customer requirements fall within the market's scope. The global forecast should be read alongside these segment definitions rather than applied uniformly to every individual category.

Within the product type classification, Cell Therapies and Gene Therapies represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Within the application classification, Oncology and Rare Genetic Disorders represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Within the end user classification, Hospitals & Specialty Treatment Centers and Research Institutes represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Drivers

Fairfield's growth discussion addresses supply chain, manufacturing and cost. These themes provide a starting point for assessing demand conditions and the requirements facing suppliers. Their commercial importance depends on the segment, customer and region concerned. Businesses can use the report's detailed discussion to connect these demand factors with their own portfolios and sales priorities.

Business Opportunity

The opportunity discussion highlights product type, application and end user. Companies evaluating expansion can compare these areas with their existing capabilities, route to market and customer needs. Segment selection and regional positioning remain central to assessing the relevance of the published forecast to an individual business.

Businesses considering Cell Therapies can compare its customer requirements with those associated with Gene Therapies. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Businesses considering Oncology can compare its customer requirements with those associated with Rare Genetic Disorders. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Businesses considering Hospitals & Specialty Treatment Centers can compare its customer requirements with those associated with Research Institutes. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Region Analysis

North America is identified in Fairfield's regional analysis as a leading market. The geographical scope covers North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Regional comparisons should use the report's own market definitions and forecast period.

Key Players

  • Novartis AG
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Vertex Pharmaceuticals Incorporated
  • bluebird bio, Inc.
  • uniQure N.V.
  • Sarepta Therapeutics, Inc.
  • Orchard Therapeutics plc
  • Legend Biotech Corporation
  • CRISPR Therapeutics AG

Segmentation

By Product Type

  • Cell Therapies
  • Gene Therapies
  • Tissue-Engineered Products
  • Others

By Application

  • Oncology
  • Rare Genetic Disorders
  • Others

By End User

  • Hospitals & Specialty Treatment Centers
  • Research Institutes

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Advanced Therapy Medicinal Products Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 3.1. Global Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Cell Therapies
    • 3.1.2. Gene Therapies
    • 3.1.3. Tissue-Engineered Products
    • 3.1.4. Others
  • 3.2. Global Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Oncology
    • 3.2.2. Rare Genetic Disorders
    • 3.2.3. Others
  • 3.3. Global Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals & Specialty Treatment Centers
    • 3.3.2. Research Institutes
  • 3.4. Global Advanced Therapy Medicinal Products Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 4.1. North America Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Cell Therapies
    • 4.1.2. Gene Therapies
    • 4.1.3. Tissue-Engineered Products
    • 4.1.4. Others
  • 4.2. North America Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Oncology
    • 4.2.2. Rare Genetic Disorders
    • 4.2.3. Others
  • 4.3. North America Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals & Specialty Treatment Centers
    • 4.3.2. Research Institutes
  • 4.4. North America Advanced Therapy Medicinal Products Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 4.4.2. U.S. Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 4.4.3. U.S. Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 4.4.5. Canada Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 4.4.6. Canada Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 5.1. Europe Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Cell Therapies
    • 5.1.2. Gene Therapies
    • 5.1.3. Tissue-Engineered Products
    • 5.1.4. Others
  • 5.2. Europe Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Oncology
    • 5.2.2. Rare Genetic Disorders
    • 5.2.3. Others
  • 5.3. Europe Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals & Specialty Treatment Centers
    • 5.3.2. Research Institutes
  • 5.4. Europe Advanced Therapy Medicinal Products Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.2. Germany Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.3. Germany Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.5. Italy Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.6. Italy Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.7. France Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.8. France Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.9. France Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.11. U.K. Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.12. U.K. Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.14. Spain Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.15. Spain Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.17. Russia Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.18. Russia Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 5.4.20. Rest of Europe Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 5.4.21. Rest of Europe Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Cell Therapies
    • 6.1.2. Gene Therapies
    • 6.1.3. Tissue-Engineered Products
    • 6.1.4. Others
  • 6.2. Asia Pacific Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Oncology
    • 6.2.2. Rare Genetic Disorders
    • 6.2.3. Others
  • 6.3. Asia Pacific Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals & Specialty Treatment Centers
    • 6.3.2. Research Institutes
  • 6.4. Asia Pacific Advanced Therapy Medicinal Products Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.2. China Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.3. China Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.5. Japan Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.6. Japan Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.8. South Korea Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.9. South Korea Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 6.4.10. India Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.11. India Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.12. India Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.14. Southeast Asia Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.15. Southeast Asia Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 6.4.17. Rest of SAO Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 6.4.18. Rest of SAO Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 7.1. Latin America Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Cell Therapies
    • 7.1.2. Gene Therapies
    • 7.1.3. Tissue-Engineered Products
    • 7.1.4. Others
  • 7.2. Latin America Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Oncology
    • 7.2.2. Rare Genetic Disorders
    • 7.2.3. Others
  • 7.3. Latin America Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals & Specialty Treatment Centers
    • 7.3.2. Research Institutes
  • 7.4. Latin America Advanced Therapy Medicinal Products Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 7.4.2. Brazil Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 7.4.3. Brazil Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 7.4.5. Mexico Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 7.4.6. Mexico Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 7.4.8. Argentina Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 7.4.9. Argentina Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 7.4.11. Rest of LATAM Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 7.4.12. Rest of LATAM Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Cell Therapies
    • 8.1.2. Gene Therapies
    • 8.1.3. Tissue-Engineered Products
    • 8.1.4. Others
  • 8.2. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Oncology
    • 8.2.2. Rare Genetic Disorders
    • 8.2.3. Others
  • 8.3. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals & Specialty Treatment Centers
    • 8.3.2. Research Institutes
  • 8.4. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 8.4.2. GCC Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 8.4.3. GCC Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 8.4.5. South Africa Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 8.4.6. South Africa Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 8.4.8. Egypt Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 8.4.9. Egypt Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 8.4.11. Nigeria Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 8.4.12. Nigeria Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Advanced Therapy Medicinal Products Market Outlook, by Product Type, 2020-2033
    • 8.4.14. Rest of Middle East Advanced Therapy Medicinal Products Market Outlook, by Application, 2020-2033
    • 8.4.15. Rest of Middle East Advanced Therapy Medicinal Products Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Novartis AG
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Gilead Sciences, Inc.
    • 9.4.3. Bristol-Myers Squibb Company
    • 9.4.4. Vertex Pharmaceuticals Incorporated
    • 9.4.5. bluebird bio, Inc.
    • 9.4.6. uniQure N.V.
    • 9.4.7. Sarepta Therapeutics, Inc.
    • 9.4.8. Orchard Therapeutics plc
    • 9.4.9. Legend Biotech Corporation
    • 9.4.10. CRISPR Therapeutics AG

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!